Related Experiment Video
Updated: Aug 23, 2025

Xenopus laevis as a Model to Identify Translation Impairment
Published on: September 27, 2015
Transcriptome analysis of the inhibitory effect of cycloleucine on myogenesis
Zhijun Wang1, Danfeng Cai1, Kan Li1
1Department of Animal Genetics, Breeding and Reproduction, College of Animal Science, South China Agricultural University, Guangzhou 510642, China; National-Local Joint Engineering Research Center for Livestock Breeding, Guangdong Provincial Key Lab of Agro-Animal Genomics and Molecular Breeding, and Key Laboratory of Chicken Genetics, Breeding and Reproduction, Ministry of Agriculture, Guangzhou 510642, China.
Abstract:
N6-Methyladenosine (m6A) has been reported to involve and play an important role in various biological activities but seldom in poultry myogenesis. Cycloleucine usually functions as a nucleic acid methylation inhibitor, the inhibition efficiency of cycloleucine at the m6A level and corresponding dynamic changes of poultry muscle cells remain unknown. In this study, we aim to find out the effect of cycloleucine on the total N6-Methyladenosine level and its molecular mechanism for regulating myogenesis. A total of 745 differentially expressed genes (DEGs) were obtained by 10 mM, 20 mM, and 30 mM of cycloleucine treatment compared with 0 mM treatment. DEGs in 10 mM cycloleucine were significantly enriched in the biological process of skeletal muscle and satellite cell proliferation and differentiation, DEGs in 20 and 30 mM cycloleucine were enriched in some metabolic and biosynthetic processes. The trend analysis showed that 85% of all DEGs were significantly clustered into 4 files, among them 59% DEGs were dose-dependent and 26% were dose-independent, 52% DEGs were in downtrend and 33% DEGs were in uptrend. Also, the cycloleucine treatment could trigger cell cycle arrest in the G1 phase and depress myoblast cell proliferation and inhibit myotube formation. In conclusion, cycloleucine could continuously reduce the m6A level of myoblast cells, depress myoblast cell proliferation and inhibit myotube formation.
Insights
Cycloleucine inhibits N6-Methyladenosine (m6A) levels in poultry myoblasts, hindering cell proliferation and myotube formation. This study reveals cycloleucine
Area of Science:
- Molecular Biology
- Epigenetics
- Poultry Science
Background:
- N6-Methyladenosine (m6A) is crucial in biological activities, but its role in poultry myogenesis is understudied.
- Cycloleucine is a known nucleic acid methylation inhibitor, yet its specific effects on m6A levels and poultry muscle development are unclear.
Purpose of the Study:
- To investigate the impact of cycloleucine on total N6-Methyladenosine (m6A) levels in poultry myoblasts.
- To elucidate the molecular mechanisms by which cycloleucine regulates myogenesis.
Main Methods:
- Treatment of poultry myoblasts with varying concentrations of cycloleucine (10, 20, 30 mM).
- Differential gene expression analysis to identify affected genes (DEGs).
- Cell cycle analysis and assessment of myoblast proliferation and myotube formation.
Main Results:
- Treatment with cycloleucine resulted in 745 differentially expressed genes (DEGs).
- Low cycloleucine concentrations (10 mM) enriched DEGs in skeletal muscle and satellite cell proliferation/differentiation.
- Higher concentrations (20, 30 mM) enriched DEGs in metabolic and biosynthetic processes, with observed cell cycle arrest in G1 phase, reduced proliferation, and inhibited myotube formation.
Conclusions:
- Cycloleucine effectively reduces m6A levels in poultry myoblast cells.
- Cycloleucine treatment inhibits myoblast proliferation and myotube formation, impacting poultry muscle development.
More Related Videos
Related Concept Videos
Formation of Muscle Fibers from Myoblasts
Muscle progenitor cells (MPCs) are formed from the myotomes. MPCs express genes that encode the transcription factors Pax3 and Pax7. Along with Pax 3/7, other transcription...
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Inhibition of Cdk Activity
Master Transcription Regulators

